Bill > H5186

This bill amends Rhode Island's Uniform Controlled Substances Act to create an exemption for psilocybin, a psychedelic compound found in certain mushrooms, allowing individuals to possess up to one ounce and cultivate it securely within their residence for personal use. The bill is contingent on the US Food and Drug Administration (FDA) rescheduling psilocybin and expanding its access program, which would then require the Rhode Island Department of Health to establish rules for cultivation, distribution, and medical prescription. Specifically, patients with serious or life-threatening mental or behavioral health disorders who lack effective medication may be granted access to psilocybin at state-approved locations. The legislation includes a sunset provision, meaning it will automatically expire on July 1, 2027, with requirements for the attorney general and health department director to provide reports to legislative leaders about psilocybin-related violations and FDA scheduling before the expiration date. The bill is set to take effect on July 1, 2025, providing a framework for potential therapeutic use of psilocybin under specific conditions and medical oversight.

Justice

https://status.rilegislature.gov/